Search Results
Trials in HER2+ NSCLC - 2022 Program: Targeted Therapies Forum
HER2+ NSCLC: When to Introduce Targeted Therapies - 2022 Program: Targeted Therapies Forum
Treatment of HER2+ NSCLC - 2022 Program: Targeted Therapies Forum
Exon 20 and HER2: The Destiny Trial - 2022 Program: Targeted Therapies Forum - English
RET+ NSCLC Treatment Options - 2022 Program: Targeted Therapies Forum
Evolving Treatment for NSCLC: Targeted Therapies - 2022 Program: Targeted Therapies Forum
Evolution of Therapy in Lung Cancer - 2022 Program: Targeted Therapies Forum
Treatment of EGFR Mutated NSCLC - 2022 Program: Targeted Therapies Forum - English
Testing for NTRK Mutations in NSCLC - 2022 Program: Targeted Therapies Forum
Changes in the Field of Metastatic NSCLC - 2022 Program: Targeted Therapies Forum - English
Full Video OnDemand -Targeted Therapies Patient Forum 2022 - for those living with Lung Cancer
Amivantamab and Lazertinib in EGFR MET+ Disease - 2022 Program: Targeted Therapies Forum - English
